132 related articles for article (PubMed ID: 1924738)
21. Influence of age on life shortening and tumor induction after X-ray and neutron irradiation.
Covelli V; Di Majo V; Bassani B; Rebessi S; Coppola M; Silini G
Radiat Res; 1984 Nov; 100(2):348-64. PubMed ID: 6387779
[TBL] [Abstract][Full Text] [Related]
22. Chemical protection against gastrointestinal radiation injury in mice by WR 2822, WR 2823, or WR 109342 after 4 MeV X ray or fission neutron irradiation.
Connor AM; Sigdestad CP
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):547-51. PubMed ID: 7107377
[TBL] [Abstract][Full Text] [Related]
23. Effect of chemical protectors on the response of the intestine to roentgen or fission neutron irradiation.
Sigdestad CP; Connor AM; Scott RM
Acta Radiol Ther Phys Biol; 1976 Oct; 15(5):401-9. PubMed ID: 1007943
[TBL] [Abstract][Full Text] [Related]
24. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
Milas L; Hunter N; Reid BO; Thames HD
Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
[TBL] [Abstract][Full Text] [Related]
25. Life shortening in mice exposed to fission neutrons and gamma rays. V. Further studies with single low doses.
Thomson JF; Williamson FS; Grahn D
Radiat Res; 1985 Dec; 104(3):420-8. PubMed ID: 4080984
[TBL] [Abstract][Full Text] [Related]
26. Life shortening in mice exposed to fission neutrons and gamma rays. VI. Studies with the white-footed mouse, Peromyscus leucopus.
Thomson JF; Williamson FS; Grahn D
Radiat Res; 1986 Nov; 108(2):176-88. PubMed ID: 3786676
[TBL] [Abstract][Full Text] [Related]
27. Induction of hprt mutations in mice after exposure to fission-spectrum neutrons or 60Co gamma rays.
Kataoka Y; Perrin J; Grdina DJ
Radiat Res; 1993 Nov; 136(2):289-92. PubMed ID: 8248487
[TBL] [Abstract][Full Text] [Related]
28. High sensitivity to hepato-tumorigenesis in hypocatalasemic C3H/C(s)b/Gen mice exposed to low doses of 252Cf fission neutrons and 60Co gamma-rays.
Yamada K; Ito A; Watanabe H; Takahashi T; Basaran NH; Gotoh T
Anticancer Res; 1997; 17(3C):2041-7. PubMed ID: 9216662
[TBL] [Abstract][Full Text] [Related]
29. In vivo protection by the aminothiol WR-2721 against neutron-induced carcinogenesis.
Carnes BA; Grdina DJ
Int J Radiat Biol; 1992 May; 61(5):567-76. PubMed ID: 1349621
[TBL] [Abstract][Full Text] [Related]
30. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
31. Late functional and biochemical changes in mouse lung after irradiation: differential effects of WR-2721.
Travis EL; Meistrich ML; Finch-Neimeyer MV; Watkins TL; Kiss I
Radiat Res; 1985 Aug; 103(2):219-31. PubMed ID: 2991972
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy of protective effect of aminopropylamino-ethylthiophosphate in neutron beam, gamma or X-irradiation of mice (author's transl)].
Sedlmeier H; Metzger E; Jentzsch U; Weitzenegger E
Strahlentherapie; 1981 Oct; 157(10):685-91. PubMed ID: 6272452
[TBL] [Abstract][Full Text] [Related]
33. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
Milas L; McBride WH; Hunter N; Ito H
Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
[TBL] [Abstract][Full Text] [Related]
34. [Chemical radioprotectors].
Ando K
Gan No Rinsho; 1987 Oct; 33(13):1679-83. PubMed ID: 2826838
[TBL] [Abstract][Full Text] [Related]
35. Options for the modified radiation weighting factor of neutrons.
Kellerer AM; Leuthold G; Mares V; Schraube H
Radiat Prot Dosimetry; 2004; 109(3):181-8. PubMed ID: 15254321
[TBL] [Abstract][Full Text] [Related]
36. Radioprotective effects of amifostine (WR-2721) or cystamine on radiation damage and its repair in rats whole body exposed to fission neutrons.
Kuna P; Dostál M; Neruda O; Volenec K; Vodicka I; Navrátil L; Petýrek P; Svoboda V; Simsa J; Vávrová J; Hermanská J; Prouza Z; Pitterman P; Listík E; Spurný F; Knajfl J; Podzimek F; Spelda S; Osterreicher J; Konrád F; Havránková R
Acta Medica (Hradec Kralove); 2004; 47(1):19-23. PubMed ID: 15168876
[TBL] [Abstract][Full Text] [Related]
37. Pathological evaluation of WR-151327 administered orally in irradiated and non-irradiated male mice.
Steel-Goodwin L; Kendrick JM; Egan JE; Eckstein JM
Ann Clin Lab Sci; 1992; 22(3):182-8. PubMed ID: 1503385
[TBL] [Abstract][Full Text] [Related]
38. Neutron carcinogenesis in mice: a study of the dose-response curves.
Covelli V; Di Majo V; Coppola M; Rebessi S
Radiat Res; 1991 Oct; 128(1 Suppl):S114-6. PubMed ID: 1924736
[TBL] [Abstract][Full Text] [Related]
39. [Chemical protection of golden hamsters against ionizing radiation].
Saĭkova VA; Sverdlov AG
Radiobiologiia; 1983; 23(2):182-6. PubMed ID: 6302728
[TBL] [Abstract][Full Text] [Related]
40. Postirradiation glucan administration enhances the radioprotective effects of WR-2721.
Patchen ML; MacVittie TJ; Jackson WE
Radiat Res; 1989 Jan; 117(1):59-69. PubMed ID: 2536480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
